Literature DB >> 30396755

Actin related protein 3 (ARP3) promotes apoptosis of intestinal epithelial cells in ulcerative colitis.

Shi-Qing Zhang1, Wen-Kai Ni2, Ming-Bing Xiao3, Feng Jiang3, Cui-Hua Lu2, Rui-Hua Wang4, Run-Zhou Ni5.   

Abstract

Apoptosis in intestinal epithelial cells (IECs) promotes the development of ulcerative colitis (UC), a type of inflammatory bowel disease (IBD). Efficient clearance of apoptotic cells is essential for tissue homeostasis in metazoans. Actin related protein 3 (ARP3) promotes endothelial dysfunction. The expression and function of ARP3 in UC remains unclear. In this study, the expression of apoptotic markers as p53, Bax, Cleaved-Caspease9 and Cleaved-Caspease3 were proved to be increased in the intestinal epithelial cells (IECs) of UC patients and in a mouse disuccinimidyl suberate(DSS)-induced colitis model; meanwhile, ARP3 expression was elevated. ARP3 expression levels and the severity of symptoms in patients with UC were positively correlated. By knocking down ARP3 in a TNF-α-treated NCM-460 cell colitis model, the apoptotic markers described above were all decreased. In conclusion, our data indicates that ARP3 might promote the apoptosis of IECs in UC, revealing a potential molecular target for treating UC.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  ARP3; Apoptosis; IBD

Mesh:

Substances:

Year:  2018        PMID: 30396755     DOI: 10.1016/j.prp.2018.10.011

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  2 in total

1.  Long non-coding RNA Mirt2 interacts with long non-coding RNA IFNG-AS1 to regulate ulcerative colitis.

Authors:  Chenyang Li; Lujia Cui; Siqiong Li; Minrui Li; Xinpu Miao
Journal:  Exp Ther Med       Date:  2020-09-01       Impact factor: 2.447

2.  miR-200b-3p alleviates TNF-α-induced apoptosis and inflammation of intestinal epithelial cells and ulcerative colitis progression in rats via negatively regulating KHDRBS1.

Authors:  Chunju Zheng; Ting Lu; Zhimin Fan
Journal:  Cytotechnology       Date:  2021-09-11       Impact factor: 2.040

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.